Raymond James Financial
XBI icon

Raymond James Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Raymond James Financial’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,700
Closed -$1.76M – 7057
2025
Q1 		$1.76M Buy
+20,700
New +$1.85M ﹤0.01% 3085

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Raymond James Financial's XBI Position: Q2 2026 in Review

Raymond James Financial increased its State Street SPDR S&P Biotech ETF (XBI) stake by 19% in Q2 2026, buying an estimated $11.2M and bringing the position to 516,322 shares worth $81.7M. The position accounts for 0.02% of the portfolio, ranked #665.

Raymond James Financial first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Raymond James Financial held 516,322 shares of State Street SPDR S&P Biotech ETF worth $81.7M as of Q2 2026.
  • Raymond James Financial bought 83,190 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $11.2M.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #665 holding.
  • Raymond James Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
  • 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.